Type 2 diabetes mellitus and invokana: An FDA approved drug

Current Diabetes Reviews

Volumn 9, Issue 6, 2013, Pages 478-490

  Akhtar, Nida ^a  

^a IFTM UNIVERSITY   (India)

Author keywords

Diabetes; Glucose; Hypoglycaemic; Insulin; Metabolism; Obesity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALBIGLUTIDE; ALEGLITAZAR; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CANAGLIFLOZIN; DAPAGLIFLOZIN; DULAGLUTIDE; EMPAGLIFLOZIN; EXENDIN 4; FASIGLIFAM; GLIBENCLAMIDE PLUS METFORMIN; GLICLAZIDE; GLIPIZIDE; IPRAGLIFLOZIN; LINAGLIPTIN; LUSEOGLIFLOZIN; MEGLITINIDE; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SITAGLIPTIN; SULFONYLUREA; TASPOGLUTIDE; UNINDEXED DRUG; VILDAGLIPTIN;

CARCINOGENESIS; CLINICAL PROTOCOL; DEHYDRATION; DISEASE SEVERITY; DIZZINESS; DRUG ABSORPTION; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; ETHNICITY; FOOD AND DRUG ADMINISTRATION; FUNGAL GENITAL INFECTION; HUMAN; INFERTILITY; METABOLISM; MICTURITION DISORDER; MUTAGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRACTICE GUIDELINE; PREVENTION STUDY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; TREATMENT PLANNING; URINARY TRACT INFECTION; VAGINITIS; WEAKNESS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG APPROVAL; FEMALE; GLUCOSIDES; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; LIFE STYLE; MALE; OBESITY; THIOPHENES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84892983453     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/15733998113096660085     Document Type: Review

References (37)

1. Joshi SK, Shrestha S. Diabetes mellitus: a review of its associations with different environmental factors. Kathmandu Univer Med J 2010; 8: 109-115.
2. Sierra GN. The global pandemic of diabetes. African J Diabetes Med 2009; 15: 4-8.
3. Gupta V, Khadgaeat R, Saraswathy KN, Sachdeva MP, Kall AK. Emergence of TCF7L2 as a most promising gene in predisposition of diabetes type-II. Int J Hum Genet 2008; 8: 199-215.
4. Panicker GK, Karnad DR, Salvi V, Kothari S. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. JAPI 2012; 60: 56-61.
5. Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invest 2005; 115: 1431-1439.
6. Baliga V, Sapsford R. Diabetes mellitus and heart failure-an overview of epidemiology and management. Diabetes Vasc Disease Res 2009; 6: 164-171.
7. Mane PB, Antre RV, Oswal RJ. Antidiabetic drugs: an overview. Int J Pharm Chem Sci 2012; 1: 301-306.
8. Jayaprasad B, Thamayandhi D, Sharavanan PS. Traditionally using anti diabetic medicinal plants in Tamil Nadu. Int J Res Pharm Bio Sci 2012; 2: 1-8.
9. Singh S. The genetics of type 2 diabetes mellitus: a review. J Scientific Res 2011; 55: 35-48.
10. Rother KI. Diabetes treatment-bridging the divide. N Eng J Med 2007; 356: 1499-1501.
11. Blagoeva K. Combined application of antidiabetic drugs. J Clin Med 2011; 4: 9-12.
12. Wild S, Roglic G, Green A, Sigree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
13. th Edition, 2012 Update. www. idf. org/diabetesatlas.
14. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB. Ethnicity, obesity and risk of type 2 diabetes in women. Diabetes Care 2006; 29: 1585-1590.
15. Mohan V, Deepa M, Farooq S, Narayan KM, Datta M, Deepa R. Anthropometric cut points for identification of cardiometabolic risk factors in an urban Asian Indian population. Metabolism Clinic Exp 2007; 56: 961-968.
16. Abate N, Chandalia M. Ethnicity and type 2 diabetes: focus on Asian Indians. J Diabetes Complications 2001; 15: 32-327.
17. Gruzman A, Babai G, Sasson S. Adenosine monophosphateactivated protein kinase (AMPK) as a new target for antidiabetic drugs: a review on metabolic; pharmacological and chemical considerations. Rev Diabet Stud 2009; 6: 13-36.
18. Pinheiro LS, deMelo AD, Andreazzi AE, Junior LCC, Costa MB, Garcia RMG. Protocol of insulin therapy for streptozotocin-diabetic rats based on a study of food ingestion and glycemic variation. Scand J Lab Anim Sci 2011; 38: 117-127.
19. th edition.
20. Aquayo-Mazzucato C, Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 2010; 6: 139-148.
21. Kemp TM, Barr EL, Zimmet PZ, et al. Glucose, lipid and blood pressure control in Australian adults with type 2 Diabetes: the 1999-2000. Aus Diab Diabetes Care 2005; 28: 1490-1492.
22. ICMR Guidelines for management of Type 2 Diabetes. 2005; 1-42.
23. Alwan AAS. Management of diabetes mellitus. Standards of care and clinical practice guidelines. WHO-EM/DIN6/E/G. 1993.
24. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65: 385-411.
25. Senayli A, Sahin A, Senayli Y, Elmastas M. Evaluation of the antidiabetic activity of Cherry Laurel (Laurocerasus officinalis). The Open Conference Proceedings J 2012; 3: 8-12.
26. Glasberg G, Baker S, Schlegel J, et al. Diabetes review and outlook: diabetes drug and device markets poised for growth. 2010; 3-96. www. pharmalive. com/special reports.
27. Karunanidhi SL, Tirumala R. Separation and quantification of eight anti-diabetic drugs on a high-performance liquid chromatography: its application to human human plasma assay. ISRN Pharma 2011; 2011: 1-7.
28. Keidan B, Hsia J, Katz R. Plasma lipids and antidiabetic agents: a brief overview. Br. J. Diabetes Vasc. Dis 2002; 2: 40-43.
29. Rana I. Diabetes Mellitus Type-II-Review of oral treatment options. Int J Pharm Pharma Sci 2010; 2: 211-30.
30. Nainggolan N. FDA accepts NDA resubmission of diabetes drug Dapagliflozin. Medscape Medical News 2013.
31. Hayat AS, Shaikh N, Ali P, Shaikh TZ, Khan AH. Clinical efficacy of gliptins for glycemic control in type 2 diabetes mellitus. World Appl Sci J 2009; 7: 1-6.
32. Diabetes drugs and medication in development. Diabetes Research.
33. U. S. Department of Health and Human Services. News and Events. FDA News Release. 2013. U. S. Food and Drug Administration.
34. Ibrahim R. Diabetes mellitus Type-II: Review of oral treatment options. Int J Pharm. Pharma Sci 2010; 2: 21-30.
35. www. centerwatch. htm.
36. http://www. janssenpharmaceuticalinc. com.
37. www. InsightPharmaReports. com.